首页> 外国专利> Stent implant for glaucoma treatment by aqueous drainage from the anterior chamber

Stent implant for glaucoma treatment by aqueous drainage from the anterior chamber

机译:前房引流支架植入术治疗青光眼

摘要

The present invention relates to a stent implant for glaucoma treatment by aqueous humor drainage from the anterior chamber, preferably into the suprachoroidal space.The stent implant according to the invention is designed to perform a change of shape after insertion into the eye, in which the width and/or thickness or the flow cross-section at least one location of the stent implant is increased by more than 20%, preferably more than 200% and particularly preferably by more than 400% is increased.In the case of aqueous humor drainage from the anterior chamber into the suprachoroidal space, a possibly opening cyclodialysis gap can be closed at least largely or completely.The proposed stent implant is particularly intended for aqueous drainage into the suprachoroidal space. With appropriate adaptations, the stent implant is also applicable for trabecular, uveoscleral, uveolsymphatic and subconjunctival applications for aqueous drainage from the anterior chamber. Even for direct aqueous drainage from the anterior chamber to the surface of the eye, an application is possible.
机译:本发明涉及一种用于青光眼治疗的支架植入物,该支架植入物通过房水从前房引流,优选地进入脉络膜上腔。根据本发明的支架植入物被设计成在插入眼睛后执行形状改变,其中支架植入物的至少一个位置的宽度和/或厚度或流动截面增加超过20%,优选超过200%,尤其优选超过400%。在房水从前房引流至脉络膜上间隙的情况下,可能存在的开放性睫状体脱离间隙至少可以大部分或完全闭合。建议的支架植入物特别适用于将水引流至脉络膜上间隙。经过适当的调整,支架植入物也适用于小梁、葡萄膜巩膜、葡萄膜联合和结膜下应用,用于前房水引流。即使是直接将房水从前房引流到眼睛表面,也可以应用。

著录项

  • 公开/公告号DE102020211175A1

    专利类型

  • 公开/公告日2022-03-10

    原文格式PDF

  • 申请/专利权人 CARL ZEISS MEDITEC AG;

    申请/专利号DE202010211175

  • 发明设计人 MARTIN HACKER;MARTIN KÜHNER;

    申请日2020-09-04

  • 分类号A61F2/82;A61F2/92;A61F9/007;

  • 国家 DE

  • 入库时间 2022-08-24 23:49:35

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号